Skip to content

Flindr Labs

Active Private limited companyfounded 2024active for 2 yearsTechnologiepark-Zwijnaarde 94, 9052 GhentKBO/BCE: BE 1014.117.578 subsidiary of

Lifetime

1 annual account with figures
peak of €294,811 in 2025
€294,811 
lowest -€591,098 in 2025
-€591,098 
peak of -€391,098 in 2025
-€391,098 
€654,026 
peak of 4.2 FTE in 2025
4.2 FTE 
Board1 name since 2024
1 director
Owners
consolidates
Documentsfilings and deeds
23-06-202638 days before the deadline
2025abbreviated format
Loss of €591,098First year with figures

Key points

from the 2025 annual accounts

Equity

-€391,098
2025

Debts exceed assets in financial year 2025.

Turnover

≈ €700,000 estimated

The abbreviated format states no turnover.

Debts

€654,026 249% of the balance sheet
Suppliers 4%Taxes and wages 5%Other 92%

Of this, €593,266 falls due within a year.

Position in the sector

-148.7%

Lower solvency than 90% of companies in pharmaceuticals. The sector median is 38.7%, over 84 companies.

Public support

€669,571 awarded in 2025

Flindr Labs was awarded €669,571 in Flemish support in 2025, mostly under Onderzoeksproject.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 7,655 companies had the same profile as Flindr Labs has now. Each dot stands for 20 companies, two years later.

84.7%
were still trading
5.8%
stopped another way
8.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • negative equity
  • a loss of 10% of the balance sheet or more

Another 0.7% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 7,655 companies, not a prediction for Flindr Labs. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 25-09-2024
  • consolidatesannual accounts 2025
Board & ownership

Recent changes

Capital contribution of €1,600,000 Capital contribution: inschrijving en storting op de bijkomende inbreng · General meeting of 01-06-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:1014117578
Incorporation . appointed as director · and ) act as permanent representatives · Founded by . · published on 27-09-2024 · Gazette deed
All 5 events

Comparable companies

same main activity, similar in size and age
Company
Flindr Labs Ghent €0.3m €294,811 -148.7% 4.2
COMED Bilzen-Hoeselt €1.3m €791,996 1.5% 8.4
272BIO Ghent €0.7m €104,252 -31.8% 5.2
Scaldis Pharma Aalst €0.3m €54,532 2.3% -
Sophie Delabie Willebroek €0.2m €81,878 56.5% -
BRUPHARM PHARMALAB Mons €0.3m €85,990 -34.5% -
BelCoPhar Kalmthout €0.2m €56,874 78.6% -

These companies have the same main activity as Flindr Labs: manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21201). They are comparable in size and age: total assets between €184,000 and €1.3m, founded between 2021 and 2024.

Official details

Source: KBO
Status
Active since 25-09-2024Normal situation
Registered office
10 active companies are registered at this addressOf these, 1 started in the 12 months before 19 November 2026. Source: KBO register, as of 19 November 2026.
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21201and 4 others
Joint committee
207White-collar workers in the chemical industry · annual accounts 2025
Establishment unit
2.364.694.1109052 Ghent, since 25-09-2024
Financial year end
31 December
Peppol
Reachable since 09-12-2025
Company details

Annual accounts 2025

€262,929
Employeeson 31-12-2025
5
Filing
Filed on 23-06-2026, 38 days before the end of the filing period
Financials

Insights on Flindr Labs

The 2025 annual accounts show negative equity of -€391,098 and a net result of -€591,098. Its solvency ranks better than 9% of 84 sector peers (NACE 21) in financial year 2025.

The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Flindr Labs

What is the company number of Flindr Labs?
The company number of Flindr Labs is 1014.117.578. The VAT number is the same number with BE in front: BE 1014.117.578.
Where is Flindr Labs based?
The registered office is at Technologiepark-Zwijnaarde 94, 9052 Ghent.Company details
What does Flindr Labs do?
According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21201).
What is the legal form of Flindr Labs?
Flindr Labs is a private limited company (BV).
When was Flindr Labs founded?
Flindr Labs was founded on 25-09-2024.
Is Flindr Labs still active?
Yes, Flindr Labs is an active enterprise in the KBO register.
How many employees does Flindr Labs have?
Flindr Labs had an average of 4.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does Flindr Labs fall under?
In its 2025 annual accounts, Flindr Labs states joint committee 207 (White-collar workers in the chemical industry).
What is the turnover of Flindr Labs?
The turnover in financial year 2025 is about €700,000. This figure is estimated from the gross margin of €294,811 and 2,136 comparable companies of the same size. It probably lies between €420,000 and €1.2m. It is a rough estimate.
Is Flindr Labs profitable?
In financial year 2025, Flindr Labs made a loss of €591,098.
Where can I find the annual accounts of Flindr Labs?
Flindr Labs filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.